Cite
Introducing Glycolinkers for the Functionalization of Cytotoxic Drugs and Applications in Antibody-Drug Conjugation Chemistry
MLA
Juhani Saarinen, et al. “Introducing Glycolinkers for the Functionalization of Cytotoxic Drugs and Applications in Antibody-Drug Conjugation Chemistry.” ChemMedChem, vol. 11, no. 22, July 2016. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....19db11961e1e7b5ff6c967e6cdc1dc9f&authtype=sso&custid=ns315887.
APA
Juhani Saarinen, Filip S. Ekholm, Anja Vilkman, Tero Satomaa, Virve Pitkänen, Henna Pynnönen, & Jari Helin. (2016). Introducing Glycolinkers for the Functionalization of Cytotoxic Drugs and Applications in Antibody-Drug Conjugation Chemistry. ChemMedChem, 11(22).
Chicago
Juhani Saarinen, Filip S. Ekholm, Anja Vilkman, Tero Satomaa, Virve Pitkänen, Henna Pynnönen, and Jari Helin. 2016. “Introducing Glycolinkers for the Functionalization of Cytotoxic Drugs and Applications in Antibody-Drug Conjugation Chemistry.” ChemMedChem 11 (22). http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....19db11961e1e7b5ff6c967e6cdc1dc9f&authtype=sso&custid=ns315887.